Alaunos Therapeutics | ZIOP - Deudores Comerciales





Deudores Comerciales Cambio Fecha
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.14B 432M 2026-03
AstraZeneca USD 17.88B 1.17B 2026-03
Baxter International USD 1.7B 310M 2026-03
Biogen USD 1.79B 76.6M 2026-03
Bioline Rx USD 699K 418K 2025-09
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Celltrion KRW 2.05T 542.39B 2025-12
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Curis USD 2.55M 400K 2024-06
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 29.99B 3.71B 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 74M 8M 2026-03
J&J USD 21.33B 3.72B 2025-12
Kangmei Pharma CNY 2.92B 228.09M 2026-03
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Merck USD 11.78B 345M 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Organigram Holdings CAD 49.94M 14.92M 2025-12
Ovoca Bio EUR 39K 408K 2025-06
Pfizer USD 16.17B 332M 2026-03
Pharma Mar EUR 51.19M 9.4M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
TG Therapeutics USD 392.05M 86.42M 2026-03
Tilray USD 109.07M 2M 2025-09
Verastem USD 9.01M 8.81M 2025-12
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.06B 60.42M 2026-03